DIFFERENTIAL DECLINE IN FILARIA-SPECIFIC IGG1, IGG4, AND IGE ANTIBODIES IN BRUGIA MALAYI-INFECTED PATIENTS AFTER DIETHYLCARBAMAZINE CHEMOTHERAPY

被引:39
|
作者
ATMADJA, AK
ATKINSON, R
SARTONO, E
PARTONO, F
YAZDANBAKHSH, M
MAIZELS, RM
机构
[1] UNIV INDONESIA, FAC MED, DEPT PARASITOL, JAKARTA, INDONESIA
[2] UNIV LONDON IMPERIAL COLL SCI TECHNOL & MED, DEPT BIOL, WELLCOME RES CTR PARASIT INFECT, LONDON, ENGLAND
[3] LEIDEN UNIV, DEPT PARASITOL, LEIDEN, NETHERLANDS
来源
JOURNAL OF INFECTIOUS DISEASES | 1995年 / 172卷 / 06期
基金
英国惠康基金;
关键词
D O I
10.1093/infdis/172.6.1567
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
In human filariasis, the predominant serum antibody is IgG4, accompanied by significant IgE production. The ratio of IgG4 to IgE is highest in asymptomatic microfilaremic carriers, while chronic disease is associated with elevated IgG1-3, The changes in isotypes following chemotherapy with diethylcarbamazine (DEC) were studied in 2 groups of Brugia malayi-infected patients from Sumatra and South Kalimantan, Indonesia, Similar results were obtained from each group, IgG4 levels decreased sharply (65%-78%) within 12 months. IgG1 levels declined in a less consistent and extreme manner, and levels of IgG2 and IgG3 declined only in patients with elephantiasis, who also had the highest initial levels of these antibodies. IgE responses were relatively stable to therapy in microfilaremic patients (7%-28% reduction) and showed only moderate decline (56% over 2 years) in elephantiasis patients, Active filarial infection is thus associated with specific IgG4 antibodies, but there is independent expression of the IgE and IgG4 isotypes in filariasis.
引用
收藏
页码:1567 / 1572
页数:6
相关论文
共 50 条
  • [41] DETERMINATION OF THE FUNCTIONAL AFFINITY OF IGG1 AND IGG4 ANTIBODIES TO TETANUS TOXOID BY ISOTYPE-SPECIFIC SOLID-PHASE ASSAYS
    DEVEY, ME
    BLEASDALE, K
    LEE, S
    RATH, S
    JOURNAL OF IMMUNOLOGICAL METHODS, 1988, 106 (01) : 119 - 125
  • [42] CAT EXTRACT IT (II) - FOLLOW-UP-STUDY OF FEL-D-I AND CAT ALBUMIN SPECIFIC IGG, IGG1, IGG4 ANTIBODIES
    CUESTA, J
    CUESTA, C
    QUIRCE, S
    LOSADA, E
    ALVAREZCUESTA, E
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1993, 91 (01) : 291 - 291
  • [43] Anti-schistosome IgG4 and IgE at 2 years after chemotherapy: Infected versus uninfected individuals
    Grogan, JL
    Kremsner, PG
    vanDam, GJ
    Deelder, AM
    Yazdanbakhsh, M
    JOURNAL OF INFECTIOUS DISEASES, 1997, 176 (05): : 1344 - 1350
  • [44] PIPE-cloned recombinant human IgE, IgG1 and IgG4 antibodies against the major birch pollen allergen Bet v 1 in the PIPEline
    Koehler, V. K.
    Singer, J. F.
    Ilieva, K. M.
    Pranger, C. L.
    Karagiannis, S. N.
    Jensen-Jarolim, E.
    ALLERGY, 2019, 74 : 370 - 370
  • [45] The clinical role of specific IgE and IgG4 antibodies in patients having immunotherapy for seasonal allergic rhinitis
    Ohashi, Y
    Nakai, Y
    Tanaka, A
    Kakinoki, Y
    Masamoto, T
    Kato, A
    Sakamoto, H
    CLINICAL OTOLARYNGOLOGY, 1998, 23 (02) : 128 - 135
  • [46] Augmented Phl p 5-specific Th2 response after exposure of dendritic cells to allergen in complex with specific IgE compared to IgG1 and IgG4
    Lundberg, Kristina
    Lindsted, Malin
    Larsson, Kristina
    Dexlin, Linda
    Wingren, Christer
    Ohlin, Mats
    Greiff, Lennart
    Borrebaeck, Carl A. K.
    CLINICAL IMMUNOLOGY, 2008, 128 (03) : 358 - 365
  • [47] Effects of 5 rounds of mass drug administration with diethylcarbamazine and albendazole on filaria-specific IgG4 titers in urine: 6-year follow-up study in Sri Lanka
    Itoh, Makoto
    Weerasooriya, Mirani V.
    Yahathugoda, Thishan C.
    Takagi, Hidekazu
    Samarawickrema, Wilfred A.
    Nagaoka, Fumiaki
    Kimura, Eisaku
    PARASITOLOGY INTERNATIONAL, 2011, 60 (04) : 393 - 397
  • [48] Mouse/human chimeric IgG1 and IgG4 antibodies directed to the house dust mite allergen Der p 2: Use in quantification of allergen specific IgG
    Schuurman, J
    Perdok, GJ
    Mueller, GA
    Benjamin, DC
    Tan, KY
    Chapman, MD
    Aalberse, RC
    CLINICAL AND EXPERIMENTAL ALLERGY, 1997, 27 (09): : 1095 - 1102
  • [49] During 3 years treatment of primary progressive multiple sclerosis with glatiramer acetate, specific antibodies switch from IgG1 to IgG4
    Basile, Erika
    Gibbs, Ebrima
    Aziz, Tariq
    Oger, Joel
    JOURNAL OF NEUROIMMUNOLOGY, 2006, 177 (1-2) : 161 - 166
  • [50] IgE and IgG4 saliva-specific antibodies in mosquito hypersensitive patients from Finland, Canada and USA
    Palosuo, K
    Peng, Z
    Simons, FER
    Engler, RJM
    Reunala, T
    BrummerKorvenkontio, H
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1996, 97 (01) : 621 - 621